- > About Us
- > CSR (Corporate Social Responsibility)
- > Promoting Environmental Management
- > Reduction of Environmental Risks
Reduction of Environmental Risks
- Preventing Air and Water Pollution
- Preventing Soil and Groundwater Contamination and its Countermeasures
- Prevention of Noise, Vibration, and Offensive Odor
- Usage reduction and emission and transfer control of chemical substances
- Storage and Usage of PCB Contaminants
- Evaluation of the Environmental Impact of Pharmaceutical Products
- Environmental Impact Assessment of the Manufacturing Process
Preventing Air and Water Pollution
To prevent air and water pollution, the Daiichi Sankyo Group has established voluntary control standards that are stricter than legal requirements and properly monitors emissions at Group plants and R&D centers in Japan. Similarly, Group company plants outside Japan, including Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.; Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd.; Daiichi Sankyo Europe GmbH, in Germany, and Daiichi Sankyo Brasil Farmacêutica LTDA., also regularly monitor their emissions to ensure compliance with the laws and regulations of their respective country and region.
Preventing Soil and Groundwater Contamination and its Countermeasures
Plants and research centers take efforts to prevent soil and groundwater contamination. When the obliged investigation is required based on the Soil Contamination Countermeasures Act and related prefectural ordinance, we conduct the appropriate investigation according to the laws and regulations on discussion with the governmental offices.
Furthermore, we similarly also conduct the investigation according to the laws and regulations even in the cases where mandatory regulations do not apply, such as closing the offices and change of using purpose.
If contamination occurs, we report it to the related government offices and properly disclose information to members of the surrounding community, and take appropriate measures (such as prevention of diffusion and purification) according to the extent of contamination. The offices that had already taken measures, such as purification, continue to monitor and report the result of analysis to governmental offices and community members.
Prevention of Noise, Vibration, and Offensive Odor
We conduct appropriate measures and continuous monitoring to comply with the laws and regulations related to noise, vibration, and offensive odor.
Usage reduction and emission and transfer control of chemical substances
We appropriately manage chemical substances that can adversely affect human health or ecosystems based on the PRTR*1 system provided in the Act on Confirmation, etc. of Release Amounts of Specific Chemical Substances in the Environment and Promotion of Improvements to the Management Thereof. The handling amount of chemical substances applicable under the PRTR system in fiscal 2016 was 3,182.0 metric tons, a 504.0 metric ton decrease compared with fiscal 2015. In addition, emissions into the air and water were 49.0 metric tons, a 34.4 metric ton decrease compared with fiscal 2015.
We will continue to reduce chemical substance use and control of emissions into the environment through the appropriate management of chemicals.
In fiscal 2015, there was no transported, imported, exported, or treated waste that was deemed hazardous nor was there any transported waste that was shipped internationally as described in the terms of the Basel Convention Annex I, II, III, and VIII.
*1 PRTR: Pollutant Release and Transfer Register
Storage and Usage of PCB Contaminants
Evaluation of the Environmental Impact of Pharmaceutical Products
The Daiichi Sankyo Group complies with environmental impact regulations and requirements by conducting the necessary environmental impact assessments for its drugs based on the guidelines of relevant countries.
The Group realizes that one of the sustainability risks associated with its business activities is the possible negative impacts of pharmaceutical manufacturing and its by-products on the environment.
There have been incidents in the past in which pharmaceutical manufacturing by-products have been detected in rivers and other natural environments. The Group is well aware that social concern is rising with regard to this issue as well as its possible environmental repercussions. To address this concern, we believe we need to coordinate with governments, industry organizations, and research institutions to realize more appropriate risk evaluations and risk management.
Environmental Impact Assessment of the Manufacturing Process
As the changes in manufacturing process for pharmaceutical products are regulated by pharmaceutical related laws and regulations, such changes require considerable time and effort. Accordingly, it is important to discuss and evaluate changes not only from a view of quality and cost, but also from a wide range of perspectives including impact on environment at the stage of research and development of manufacturing process. When developing manufacturing processes for new products, the Daiichi Sankyo Group uses its own evaluation indicators*2 to determine the impact of these processes on the environment. This approach is based on the concept of eco-friendly green chemistry. Through this approach, we aim to create manufacturing processes that are considerate of the sustainability of the natural environment by developing new synthetic processes, preventing pollution, and reducing resource and energy consumption.
For manufacturing processes that produce waste, we discuss and evaluate methods through which the waste can be collected and reused as well as methods of treating this waste that are highly safe and have a low environmental impact.
The result of this research leads to a great reduction of the environmental impact of the final manufacturing process (industrialized manufacturing method) compared with the impact when this research had just begun.
- *2 Indicators established by scoring the items such as the safety or toxicity, operating condition, and waste volumes, etc., of solvents or reagents